U.S. pharma big copyright scrapped two experimental weight loss drugs very last 12 months—a when-daily pill, lotiglipron, because of elevated liver enzymes along with a twice-daily capsule, danuglipron, because of potent Unintended effects—but CEO Albert Bourla has explained the company is decided to “play and acquire” inside the being over